UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 65

Sortiert nach

The Normal Phenotype of Pmm1-Deficient Mice Suggests that Pmm1 Is Not Essential for Normal Mouse Development

Molecular and Cellular Biology, 2006-08, Vol.26 (15), p.5621-5635

2006

Volltextzugriff (PDF)

Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2

FEBS letters, 1999-06, Vol.452 (3), p.319-322

1999

Volltextzugriff (PDF)

Identification and localization of two mouse phosphomannomutase genes, Pmm1 and Pmm2

Gene, 2001-05, Vol.270 (1), p.53-59

2001

Volltextzugriff (PDF)

Phosphomannomutase Deficiency: The Molecular Basis of the Classical Jaeken Syndrome (CDGS Type Ia)

Molecular Genetics and Metabolism, 1999-10, Vol.68 (2), p.220-226

1999

Volltextzugriff (PDF)

Comparative Analysis of the Phosphomannomutase Genes PMM1, PMM2 and PMM2Ψ: The Sequence Variation in the Processed Pseudogene is a Reflection of the Mutations Found in the Functional Gene

Human molecular genetics, 1998-02, Vol.7 (2), p.157-164

1998

Volltextzugriff (PDF)

Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene

Human molecular genetics, 1998-02, Vol.7 (2), p.157-164

1998

Volltextzugriff (PDF)

Linearity of pharmacokinetics and model estimation of sufentanil

Anesthesiology (Philadelphia), 1995-12, Vol.83 (6), p.1194-1204

1995

Volltextzugriff (PDF)

Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat

Psychopharmacologia, 1994-02, Vol.114 (1), p.53-62

1994

Volltextzugriff (PDF)

Absorption, metabolism, and excretion of risperidone in humans

Drug metabolism and disposition, 1993-11, Vol.21 (6), p.1134

1993

Volltextzugriff (PDF)

A predictive model for substrates of cytochrome P450-debrisoquine (2D6)

Chemical research in toxicology, 1992-03, Vol.5 (2), p.211-219

1992

Volltextzugriff (PDF)

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects

Clinical pharmacology and therapeutics, 1993-09, Vol.54 (3), p.257-268

1993

Volltextzugriff (PDF)

Effect of Food on the Pharmacokinetics of a New Hydroxypropyl-β-Cyclodextrin Formulation of Itraconazole

Pharmacotherapy, 1996-05, Vol.16 (3), p.424-428

1996

Volltextzugriff (PDF)

Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations

Antimicrobial Agents and Chemotherapy, 1993-10, Vol.37 (10), p.2224-2227

1993

Volltextzugriff (PDF)

The pharmacokinetics of sufentanil in surgical patients

Anesthesiology (Philadelphia), 1984-11, Vol.61 (5), p.502-506

1984

Volltextzugriff (PDF)

The pharmacokinetics of risperidone in humans: a summary

The journal of clinical psychiatry, 1994-05, Vol.55 Suppl, p.13

1994

Volltextzugriff (PDF)

The metabolism and excretion of risperidone after oral administration in rats and dogs

Drug metabolism and disposition, 1994-01, Vol.22 (1), p.129

1994

Volltextzugriff (PDF)

Assay methods for sufentanil in plasma : radioimmunoassay versus gas chromatography-mass spectrometry

Anesthesiology (Philadelphia), 1994-03, Vol.80 (3), p.666-670

1994

Volltextzugriff (PDF)

Gastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog

Drug metabolism and disposition, 1995-02, Vol.23 (2), p.216

1995

Volltextzugriff (PDF)

Pharmacokinetics and Dose Proportionality of Domperidone in Healthy Volunteers

Journal of clinical pharmacology, 1986-11, Vol.26 (8), p.628-632

1986

Volltextzugriff (PDF)

Induction potential of fluconazole toward drug-metabolizing enzymes in rats

Antimicrobial Agents and Chemotherapy, 1990-03, Vol.34 (3), p.402-408

1990

Volltextzugriff (PDF)

Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers

Antimicrobial Agents and Chemotherapy, 1986-08, Vol.30 (2), p.206-210

1986

Volltextzugriff (PDF)

Is the metabolism of alfentanil subject to debrisoquine polymorphism? a study using human liver microsomes

Anesthesiology (Philadelphia), 1988-10, Vol.69 (4), p.535-540

1988

Volltextzugriff (PDF)

Narcotic analgesics and debrisoquine polymorphism

Anesthesiology (Philadelphia), 1989-09, Vol.71 (3), p.474-474

1989

Volltextzugriff (PDF)

Population analysis of the non linear red blood cell partitioning and the concentration‐effect relationship of draflazine following various infusion rates

British journal of clinical pharmacology, 1997-06, Vol.43 (6), p.603-612

1997

Volltextzugriff (PDF)

1 – 25 von 65

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(60)
Mit Volltextzugriff
(44)

Publikationsform

Artikel
(64)
Berichte
(1)

Sprache

Englisch
(65)
Japanisch
(6)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Normal Phenotype of Pmm1-Deficient Mice Suggests that Pmm1 Is Not Essential for Normal Mouse Development

Effect of mutations found in carbohydrate-deficient glycoprotein syndrome type IA on the activity of phosphomannomutase 2

Identification and localization of two mouse phosphomannomutase genes, Pmm1 and Pmm2

Phosphomannomutase Deficiency: The Molecular Basis of the Classical Jaeken Syndrome (CDGS Type Ia)

Carbohydrate-deficient glycoprotein syndromes become congenital disorders of glycosylation: An updated nomenclature for CDG

Comparative Analysis of the Phosphomannomutase Genes PMM1, PMM2 and PMM2Ψ: The Sequence Variation in the Processed Pseudogene is a Reflection of the Mutations Found in the Functional Gene

Comparative analysis of the phosphomannomutase genes PMM1, PMM2 and PMM2psi: the sequence variation in the processed pseudogene is a reflection of the mutations found in the functional gene

Linearity of pharmacokinetics and model estimation of sufentanil

Regional brain distribution of risperidone and its active metabolite 9-hydroxy-risperidone in the rat

Absorption, metabolism, and excretion of risperidone in humans

A predictive model for substrates of cytochrome P450-debrisoquine (2D6)

Pharmacokinetics of the novel antipsychotic agent risperidone and the prolactin response in healthy subjects

Effect of Food on the Pharmacokinetics of a New Hydroxypropyl-β-Cyclodextrin Formulation of Itraconazole

Discrepancies in bioassay and chromatography determinations explained by metabolism of itraconazole to hydroxyitraconazole: studies of interpatient variations in concentrations

The pharmacokinetics of sufentanil in surgical patients

The pharmacokinetics of risperidone in humans: a summary

The metabolism and excretion of risperidone after oral administration in rats and dogs

Assay methods for sufentanil in plasma : radioimmunoassay versus gas chromatography-mass spectrometry

Gastrointestinal distribution of the prodrug loperamide oxide and its active drug loperamide in the dog

Pharmacokinetics and Dose Proportionality of Domperidone in Healthy Volunteers

Induction potential of fluconazole toward drug-metabolizing enzymes in rats

Pharmacokinetics and dose proportionality of ketoconazole in normal volunteers

Is the metabolism of alfentanil subject to debrisoquine polymorphism? a study using human liver microsomes

Narcotic analgesics and debrisoquine polymorphism

Population analysis of the non linear red blood cell partitioning and the concentration‐effect relationship of draflazine following various infusion rates

Suchergebnisse filtern